Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9132174
Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
granted patentUS 9133200
Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors
granted patentUS 9125922
Phosphate esters of gyrase and topoisomerase inhibitors
granted patentUS 9127021
Hepatitis C virus inhibitors
granted patentUS 9126956
Neprilysin inhibitors
granted patentUS 9119837
Use of sEH inhibitors as analgesics
granted patentUS 9120790
Azaindoles useful as inhibitors of Janus kinases
granted patentUS 9120758
Neprilysin inhibitors
granted patentUS 9120747
Neprilysin inhibitors
granted patentUS 9120744
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid
granted patentUS 9108934
Neprilysin inhibitors
granted patentUS 9096496
Neprilysin inhibitors
granted patentUS 9096625
BCL-2/BCL-XL inhibitors and therapeutic methods using the same
granted patentUS 9096609
Macrocyclic LRRK2 kinase inhibitors
granted patentUS 9096602
Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors
granted patentUS 9096584
Compounds useful as inhibitors of ATR kinase
granted patentUS 9096542
Kinase inhibitors and their uses
granted patentUS 9096501
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid
granted patentUS 9095593
Protein kinase C inhibitors and uses thereof
granted patentUS 9090597
Pyrazolone derivatives as PDE4 inhibitors
granted patentUS 9090630
Macrocyclic FLT3 kinase inhibitors
granted patentUS 9090589
Specific nNOS inhibitors for the therapy and prevention of human melanoma
granted patentUS 9089545
Small molecule RNase inhibitors and methods of use
granted patentUS 9084782
Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
granted